Genmab A/S Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement
Genmab A/S (GMAB) had Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement of DKK 284.65 billion as of 2020-06-30, per its 6-K filed 2020-08-12.
Discontinued › Notes › Compensation Related Costs
ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement · last filed 2020-08-12
- 2020-06-30: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 284.65B DKK.
- 2019-12-31: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 307.91B DKK.
- 2019-06-30: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 207.09B DKK.
- 2018-12-31: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 218.90B DKK.
| Period end | Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement |
|---|---|
| 2020-06-30 | 284.65B DKK 6-K · filed 2020-08-12 |
| 2019-12-31 | 307.91B DKK 6-K · filed 2020-08-12 |
| 2019-06-30 | 207.09B DKK 6-K · filed 2020-08-12 |
| 2018-12-31 | 218.90B DKK 6-K · filed 2020-08-12 |